ArticleJournal of glaucoma2025
Association Between Sociodemographic Risk Factors and No-Show Propensity in a Glaucoma Population Before and During COVID-19 Pandemic.
Article in Journal of glaucoma, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Identification of Risk Factors for Glaucoma Progression in Free-Text Clinical Notes Using a Local Large Language Model.Translational vision science & technology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
PRÉCIS: Greater social vulnerability, younger age, nonwhite race, Hispanic ethnicity, non-English speaking, Medicaid insurance, and milder glaucoma were associated with a higher no-show propensity, which worsened during the COVID-19 pandemic among those subjects who were older and more socially vulnerable. PURPOSE: To identify sociodemographic risk factors for a higher likelihood to no-show among glaucoma subjects before and during the COVID-19 pandemic using the no-show propensity factor (NSPF), a novel attendance metric, which improves upon no-show percentages by adjusting for number of visits.
methodsWe analyzed deidentified demographic, visit attendance, and social risk factor data [social vulnerability index (SVI) and area deprivation index (ADI) scores] of deidentified glaucoma subjects from the Bascom Palmer Glaucoma Repository, computed NSPF, and categorized scores as low, intermediate, or high by the 75th and 90th percentiles for the prepandemic and pandemic periods. We identified predictors of NSPF scores using univariable, multivariable, and logistic regression analyses.
resultsOf 15,342 subjects, 11,474, 2238, and 1630 subjects had low, intermediate, and high NSPF scores, respectively, with no-show rates of 9.5%, 39.2%, and 57.8%, respectively. Age (β=-0.039 per decade, P <0.001), Black race (β=0.152, P <0.001), Hispanic ethnicity (β=0.115, P <0.001), Medicaid (β=0.073, P <0.001), Spanish primary language (β=0.076, P <0.001), SVI scores (β=0.047 per 25% increase, P <0.001), ADI ranking (β=0.057 for highest quartile, P <0.001), and baseline moderate (β=-0.046, P <0.001) or severe (β=-0.077, P <0.001) glaucomatous disease were significant predictors of NSPF. Older age [odds ratio (OR) 1.15 per decade, P <0.001], higher overall SVI (OR: 1.09 per 25% increase, P <0.001), Medicare/Tricare insurance (OR: 1.13, P =0.044), and non-English/Spanish primary language (OR: 1.43, P =0.020) were associated with worsening NSPF during the pandemic.
conclusionYounger age, nonwhite race, Hispanic ethnicity, non-English primary language, Medicaid, milder glaucoma, and residence in vulnerable areas are risk factors for greater propensity to no-show.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.